Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

CD Maps - Dynamic Profiling of CD1 to CD100 Surface Expression on Human Leukocyte and Lymphocyte Subsets

Karel Fišer, PhD, Tomas Kalina, MD PhD, Martin Perez-Andres, Daniela Kužílková, PhD, Pablo Engel, Marta Cuenca, PhD, Elena Blanco Álvarez, Sophinus J.W. Bartol, Menno C. van Zelm

Blood (2019) 134 (Supplement_1): 4878.

https://doi.org/10.1182/blood-2019-128123

Published: 2019

Journal Articles

Pharmacokinetics-Guided Dosing of Hydroxyurea Can Achieve Near-Pancellular Fetal Hemoglobin Expression in Sickle Cell Anemia: F-Cell Analysis As a Benchmark for Disease-Modifying Therapy

Charles T. Quinn, MD, Omar Niss, MD, Amanda Pfeiffer, Jennifer Korpik, Holly Bonar, Mary Reynaud, Russell E. Ware, MD PhD, Patrick T. McGann, MD

Blood (2019) 134 (Supplement_1): 892.

https://doi.org/10.1182/blood-2019-130414

Published: 2019

Journal Articles

Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark

Justin Taylor, Michael Haddadin, Vivek A. Upadhyay, Erwin Grussie, Neha Mehta-Shah, Andrew M. Brunner, Abner Louissaint, Jr, Scott B. Lovitch, Ahmet Dogan, Amir T. Fathi, Richard M. Stone, Martin S. Tallman, Raajit K. Rampal, Donna S. Neuberg, Kristen E. Stevenson, Steven M. Horwitz, Andrew A. Lane

Blood (2019) 134 (8): 678–687.

https://doi.org/10.1182/blood.2019001144

Published: 2019

Includes: Supplemental data

Journal Articles

The role of JAK2 inhibitors in MPNs 7 years after approval

Francesco Passamonti, Margherita Maffioli

Blood (2018) 131 (22): 2426–2435.

https://doi.org/10.1182/blood-2018-01-791491

Published: 2018

Journal Articles

Resource Utilization Associated with the Management of Adults with Hemophagocytic Lymphohistiocytosis (HLH): A Benchmark Analysis for Improving Inpatient Care at a Quaternary Hospital

Eric Lau, DO, Cynthia Gong, Pharm.D, Haley Weiner, Michael R. Jeng, MD, Natasha Purington, MS, Beth A Martin, MD

Blood (2017) 130 (Supplement 1): 3363.

https://doi.org/10.1182/blood.V130.Suppl_1.3363.3363

Published: 2017

Journal Articles

Gastrointestinal Toxicity of High-Dose Melphalan in Autologous Stem-Cell Transplantation: Identification of Risk Factors and a Benchmark for Experimental Therapies

Christian Gordillo, BS, Sapna Parmar, PharmD, Miranda Blanco, BS, Elsa Marie Delille, NP, Amer Assal, MD, Markus Y Mapara, MD PhD, Ran Reshef, MDMSc

Blood (2017) 130 (Supplement 1): 5464.

https://doi.org/10.1182/blood.V130.Suppl_1.5464.5464

Published: 2017

Journal Articles

Estimating the Need for Complex Malignant Hematologists in Ontario Using Monte Carlo Simulation

Jonathan Wang, MASc, Andre C. Schuh, MD FRCPC, Deanna Wu, MBA, Christopher N. Bredeson, MD MSc, FRCPC, Jacinta Meharchand, MD FRCPC, Lisa Favell, MBA, Louis Fu, MISt, Kelly J. Woltman, MA, C. Tom Kouroukis, MDMSc,FRCPC

Blood (2017) 130 (Supplement 1): 3397.

https://doi.org/10.1182/blood.V130.Suppl_1.3397.3397

Published: 2017

Journal Articles

Genome-Wide Analysis of the Regulatory Landscape in Different Pre-B-ALL Subtypes

Mari Lahnalampi, MSc, Juha Mehtonen, MSc, Susanna Teppo, MSc, Saara Laukkanen, MSc, Laura Oksa, MSc, Markus Muschen, MD, Olli Lohi, MD PhD, Merja Heinäniemi, PhD

Blood (2017) 130 (Supplement 1): 3807.

https://doi.org/10.1182/blood.V130.Suppl_1.3807.3807

Published: 2017

Journal Articles

Lymphoma “benchmark” or “bench-smudge”?

Sarah C. Rutherford, John P. Leonard

Blood (2017) 130 (16): 1778–1779.

https://doi.org/10.1182/blood-2017-08-800730

Published: 2017

Journal Articles

Benchmark of Progression Free Survival for Multiple Lines of Therapy in Follicular Lymphoma Treated in the Rituximab Era

Blood (2016) 128 (22): 2955.

https://doi.org/10.1182/blood.V128.22.2955.2955

Published: 2016

Journal Articles

Diffuse Large B-Cell Lymphoma with Primary Treatment Failure: Identification of Ultra-High Risk Patients and Benchmarking for Experimental Therapies

Blood (2016) 128 (22): 103.

https://doi.org/10.1182/blood.V128.22.103.103

Published: 2016

Journal Articles

De Novo DNA Methylation Is Associated with Granulopoiesis and Megakaryopoiesis but Not Erythropoiesis

Jens Lichtenberg, PhD, Elisabeth F. Heuston, PhD, Stacie M. Anderson, NIH Intramural Sequencing Center, Cheryl A. Keller, PhD, Ross C. Hardison, PhD, David M. Bodine, PhD

Blood (2016) 128 (22): 3868.

https://doi.org/10.1182/blood.V128.22.3868.3868

Published: 2016

Journal Articles

Impact of Non Professional Physicians' Characteristics on Medical Decision Making in Older Patients with Acute Myeloid Leukemia

Pierre Bories, MD, Sébastien Lamy, PhD, Celestine Simand, Sarah Bertoli, MD PhD, Sandra Malak, MD, Luc Mathieu Fornecker, MD PhD, Stephane Moreau, MD, Christian Recher, MD PhD, Antoine Nebout, PhD

Blood (2016) 128 (22): 3576.

https://doi.org/10.1182/blood.V128.22.3576.3576

Published: 2016

Journal Articles

Age and Gender-Related Pretreatment Quality of Life Profiles in Patients with Higher-Risk Myelodysplastic Syndromes. Establishing Benchmark Data from an International Study

Fabio Efficace, PhD, Gianluca Gaidano, MD PhD, Massimo Breccia, MD, Pasquale Niscola, MD, Francesco Cottone, Luana Fianchi, Maria Teresa Voso, Giovanni Caocci, Francesco Buccisano, Emanuele Angelucci, MD, Valeria Santini, MD, Reinhard Stauder, MD MSc, Uwe Platzbecker, MD, Alessandra Ricco, MD, Nicola Di Renzo, David Bowen, MD PhD, Franco Mandelli, MD

Blood (2015) 126 (23): 2099.

https://doi.org/10.1182/blood.V126.23.2099.2099

Published: 2015

Journal Articles

Value-Based Health Care (VBHC) in Sickle Cell Disease: A Dutch Initiative

Fia ten Brink, MD, Anita W. Rijneveld, MD PhD, Marie-José J.A.G. Claessen, MD, Amando J. Heesterman, Thea J. van Zon, Sonja A.M.C. Teuben, Cora J.D. Onna Van - Walraven, Alice M.A. Goncalves Silva, Francis van Veelen, Renée du Mortier, Marieke A.M.S. Joosten, MD PhD, Fred Petrij, MD PhD, Jan A. Hazelzet, MD PhD, Marjon H. Cnossen, MD PhD

Blood (2015) 126 (23): 5572.

https://doi.org/10.1182/blood.V126.23.5572.5572

Published: 2015

Journal Articles

Clonal Hematopoiesis with Somatic Mutations Is a Common, Age-Related Condition Associated with Adverse Outcomes

Blood (2014) 124 (21): 840.

https://doi.org/10.1182/blood.V124.21.840.840

Published: 2014

Journal Articles

From Bedside To Bench: Molecular Benchmarking Of An Fc-Optimized CD19 Antibody Used In Treatment Of Relapsed and Refractory Pediatric B-Lineage Acute Lymphoblastic Leukemia

Ursula J.E. Seidel, Ludger Grosse-Hovest, PhD, Patrick Schlegel, MD, Martin Hofmann, Friedhelm R. Schuster, MD, Kai-Erik Witte, Steffen Aulwurm, PhD, Rouwen Teltschik, Elwira Pyz, PhD, Hans-Georg Rammensee, Gundram Jung, MD, Rupert Handgretinger, Prof., Peter Lang, MD

Blood (2013) 122 (21): 3905.

https://doi.org/10.1182/blood.V122.21.3905.3905

Published: 2013

Journal Articles

Genetic and Epigenetic Profile Of Early Relapsed Childhood ALL

Yucel Erbilgin, Ozden Hatirnaz Ng, PhD, Sinem Firtina, Tiraje Celkan, Sema Anak, MD, Zeynep Karakas, MD, Aykan Ozguven, MD, Nazan Sarper, MD, Emine Zengin, MD, Emine Turkkan, MD, Didem Yalcin Atay, MD, Yuk Yin Ng, PhD, Omer Dogru, MD, Muge Sayitoglu, PhD, Ugur Ozbek

Blood (2013) 122 (21): 1380.

https://doi.org/10.1182/blood.V122.21.1380.1380

Published: 2013

Journal Articles

Adding AB Plasma Units to Emergency Release O Negative Red Blood Cells (RBC) Issued to the Emergency Department (ED)

Jennifer C. Andrews, Susan Weiss, Maurene Viele, Lawrence T Goodnough

Blood (2011) 118 (21): 4333.

https://doi.org/10.1182/blood.V118.21.4333.4333

Published: 2011

Journal Articles

Red Blood Cell (RBC) Turn-Around-Time (TAT) From the Transfusion Service (TS) to the Operating Room (OR)

Jonathan Hughes, Jennifer C. Andrews, Maurene Viele, Lawrence T Goodnough

Blood (2011) 118 (21): 4338.

https://doi.org/10.1182/blood.V118.21.4338.4338

Published: 2011

NARROW

CD Maps - Dynamic Profiling of CD1 to CD100 Surface Expression on Human Leukocyte and Lymphocyte Subsets

Pharmacokinetics-Guided Dosing of Hydroxyurea Can Achieve Near-Pancellular Fetal Hemoglobin Expression in Sickle Cell Anemia: F-Cell Analysis As a Benchmark for Disease-Modifying Therapy

Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark

The role of JAK2 inhibitors in MPNs 7 years after approval

Resource Utilization Associated with the Management of Adults with Hemophagocytic Lymphohistiocytosis (HLH): A Benchmark Analysis for Improving Inpatient Care at a Quaternary Hospital

Gastrointestinal Toxicity of High-Dose Melphalan in Autologous Stem-Cell Transplantation: Identification of Risk Factors and a Benchmark for Experimental Therapies

Estimating the Need for Complex Malignant Hematologists in Ontario Using Monte Carlo Simulation

Genome-Wide Analysis of the Regulatory Landscape in Different Pre-B-ALL Subtypes

Lymphoma “benchmark” or “bench-smudge”?

Benchmark of Progression Free Survival for Multiple Lines of Therapy in Follicular Lymphoma Treated in the Rituximab Era

Diffuse Large B-Cell Lymphoma with Primary Treatment Failure: Identification of Ultra-High Risk Patients and Benchmarking for Experimental Therapies

De Novo DNA Methylation Is Associated with Granulopoiesis and Megakaryopoiesis but Not Erythropoiesis

Impact of Non Professional Physicians' Characteristics on Medical Decision Making in Older Patients with Acute Myeloid Leukemia

Age and Gender-Related Pretreatment Quality of Life Profiles in Patients with Higher-Risk Myelodysplastic Syndromes. Establishing Benchmark Data from an International Study

Value-Based Health Care (VBHC) in Sickle Cell Disease: A Dutch Initiative

Clonal Hematopoiesis with Somatic Mutations Is a Common, Age-Related Condition Associated with Adverse Outcomes

From Bedside To Bench: Molecular Benchmarking Of An Fc-Optimized CD19 Antibody Used In Treatment Of Relapsed and Refractory Pediatric B-Lineage Acute Lymphoblastic Leukemia

Genetic and Epigenetic Profile Of Early Relapsed Childhood ALL

Adding AB Plasma Units to Emergency Release O Negative Red Blood Cells (RBC) Issued to the Emergency Department (ED)

Red Blood Cell (RBC) Turn-Around-Time (TAT) From the Transfusion Service (TS) to the Operating Room (OR)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only